← Insiders

VEEV

Neutral signalScored 2026-10-27 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.

Research, not advice.

À propos

Veeva Systems Inc.

Nom
Veeva Systems Inc.
Secteur
Technology
Industrie
Software - Application
Bourse
NYSE
Capitalisation
$52.4B
Employés
7,928
PDG
Peter Gassner
Site web
https://www.veeva.com
Marché
DOCSHCTIHSTMIQVSDGR

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

VENTE TOTALE: 750 titres (~195 780,38 $ US)

Insiders
Hung Priscilla
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$4,030,683

Avg sell (VWAP, 90d window) $276.11 vs last close $318.18 (+15.2%)

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

$3,746,240 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.

Last activity
2026-09-09
Liquidity
Liquid $462,558,248/day · 20d vol
Last synced
2026-10-27 04:43:11 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-10-14 Faddis Jonathan Sell · S · 10b5-1 708 $298.19 $211,120 Form 4
2026-10-02 Rizzo Daniel J Sell · S 321 $276.21 $88,662 Form 4
2026-09-14 Schwenger Thomas D. Sell · S · 10b5-1 1,000 $265.20 $265,200 Form 4
2026-09-09 Hung Priscilla Sell · S 750 $261.04 $195,780 Form 4
2026-08-27 Schwenger Thomas D. Sell · S · 10b5-1 10,000 $281.33 $2,813,300 Form 4
2026-08-13 Schwenger Thomas D. Sell · S · 10b5-1 1,819 $251.03 $456,620 Form 4

Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent trades

DateRepresentativeTypeAmount
2026-06-02Ro KhannaPurchase$1,001 - $15,000
2025-05-29Robert P. BresnahanPurchase$1,001 - $15,000
2025-05-16Robert P. BresnahanSale (Full)$1,001 - $15,000
2025-03-20Byron DonaldsSale (Full)$1,001 - $15,000
2025-03-20Byron DonaldsSale (Full)$1,001 - $15,000
2024-07-16John JamesSale (Full)$1,001 - $15,000
2023-11-10John JamesPurchase$1,001 - $15,000
2023-05-23Ro KhannaSale$1,001 - $15,000
2023-02-13William R. KeatingPurchase$1,001 - $15,000
2023-01-11Ro KhannaPurchase$1,001 - $15,000
2022-11-03Ro KhannaSale$1,001 - $15,000
2022-05-23Ro KhannaPurchase$1,001 - $15,000
2022-02-17Ro KhannaSale$1,001 - $15,000
2022-01-21Ro KhannaPurchase$1,001 - $15,000
2022-01-20Ro KhannaSale$1,001 - $15,000
2022-01-11Ro KhannaPurchase$1,001 - $15,000
2021-03-17William R. KeatingPurchase$1,001 - $15,000
2021-03-04Josh GottheimerSale (Full)$1,001 - $15,000
2020-11-16Josh GottheimerSale (Partial)$1,001 - $15,000
2020-09-14Josh GottheimerSale (Partial)$1,001 - $15,000
2020-07-22Greg GianforteSale (Full)$100,001 - $250,000
2020-06-19Greg GianforteSale (Partial)$100,001 - $250,000
2020-05-07Greg GianforteSale (Partial)$100,001 - $250,000
2019-06-06Greg GianforteSale (Partial)$100,001 - $250,000
2018-10-17Josh GottheimerPurchase$1,001 - $15,000

Signal

Neutral signalScored 2026-10-27 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.

Veeva Systems exhibits exceptional financial health — near-zero debt, expanding margins, and strong cash generation — which anchors a solid fundamental base.

The first sentence of the analysis written for VEEV on 2026-10-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
  • Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
  • Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
  • Timing Supports a bullish reading. Interesting trend — weekly bias up
  • Financial indicators Supports a bullish reading. Current ratio 4.89 · operating margin 29%

Suggested stop 277.49, nearest stored support minus 0.5 ATR(12.8% under the last close). Research, not advice. Not an order.

Recent news

Market snapshot

Financial ratios

MetricTrend2026-01-312025-01-312024-01-312023-01-312022-01-31
Gross Profit Margin75.5%74.5%71.3%71.7%72.8%
Ebit Margin37.4%33.5%24.9%23.6%27.7%
Ebitda Margin39.0%34.9%26.4%25.4%29.7%
Operating Profit Margin28.7%25.2%18.2%21.3%27.3%
Pretax Profit Margin37.4%33.5%24.9%23.6%27.7%
Continuous Operations Profit Margin28.4%26.0%22.2%22.6%23.1%
Net Profit Margin28.4%26.0%22.2%22.6%23.1%
Bottom Line Profit Margin28.4%26.0%22.2%22.6%23.1%
Current Ratio4.8854.5114.2443.9423.696
Quick Ratio4.8854.5114.2443.9423.696
Solvency Ratio0.5440.5000.4450.4830.513
Cash Ratio0.8680.8000.5970.8801.354
Price To Earnings Ratio36.74252.89363.42854.31584.781
Price To Earnings Growth Ratio1.4211.51715.3204.3307.913
Forward Price To Earnings Growth Ratio1.4211.51715.3204.3307.913
Price To Earnings Diluted Ratio37.48553.99564.41356.85089.939
Price To Earnings Diluted Growth Ratio1.4461.5818.7844.0417.861
Price To Book Ratio4.6266.4747.1687.13112.450
Price To Sales Ratio10.44513.74814.08712.29719.586
Price To Free Cash Flow Ratio24.07835.30537.61634.55348.317
Price To Operating Cash Flow Ratio23.58334.64036.53533.95547.419
Debt To Assets Ratio0.0110.0100.0090.0130.014
Debt To Equity Ratio0.0130.0130.0120.0160.019
Debt To Capital Ratio0.0130.0130.0120.0160.018
Long Term Debt To Capital Ratio0.0000.0000.0000.0000.000
Financial Leverage Ratio1.2451.2581.2731.2931.311
Working Capital Turnover Ratio0.5670.6290.6970.8240.959
Operating Cash Flow Ratio0.8640.7790.7730.7750.909
Operating Cash Flow Sales Ratio0.4430.3970.3860.3620.413
Free Cash Flow Operating Cash Flow Ratio0.9790.9810.9710.9830.981
Debt Service Coverage Ratio0.0000.0000.0000.0000.000
Interest Coverage Ratio0.0000.0000.0000.0000.000
Short Term Operating Cash Flow Coverage Ratio0.0000.0000.0000.0000.000
Operating Cash Flow Coverage Ratio14.76414.38516.34012.80014.004
Capital Expenditure Coverage Ratio48.58153.12434.78957.76153.782
Dividend Paid And Capex Coverage Ratio48.58153.12434.78957.76153.782
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple25.74338.29652.22346.95964.023

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 75.5% ▲1.0% ▲2.3%
Ebit Margin 37.4% ▲3.9% ▲8.0%
Ebitda Margin 39.0% ▲4.1% ▲7.9%
Operating Profit Margin 28.7% ▲3.5% ▲4.5%
Pretax Profit Margin 37.4% ▲3.9% ▲8.0%
Continuous Operations Profit Margin 28.4% ▲2.4% ▲4.0%
Net Profit Margin 28.4% ▲2.4% ▲4.0%
Bottom Line Profit Margin 28.4% ▲2.4% ▲4.0%
Current Ratio 4.885 ▲0.374 ▲0.630
Quick Ratio 4.885 ▲0.374 ▲0.630
Solvency Ratio 0.544 ▲0.044 ▲0.047
Cash Ratio 0.868 ▲0.068 ▼-0.032
Price To Earnings Ratio 36.742 ▼-16.151 ▼-21.690
Price To Earnings Growth Ratio 1.421 ▼-0.096 ▼-4.679
Forward Price To Earnings Growth Ratio 1.421 ▼-0.096 ▼-4.679
Price To Earnings Diluted Ratio 37.485 ▼-16.510 ▼-23.051
Price To Earnings Diluted Growth Ratio 1.446 ▼-0.135 ▼-3.297
Price To Book Ratio 4.626 ▼-1.848 ▼-2.944
Price To Sales Ratio 10.445 ▼-3.303 ▼-3.588
Price To Free Cash Flow Ratio 24.078 ▼-11.227 ▼-11.896
Price To Operating Cash Flow Ratio 23.583 ▼-11.058 ▼-11.644
Debt To Assets Ratio 0.011 ▲0.000 ▼-0.001
Debt To Equity Ratio 0.013 ▲0.000 ▼-0.001
Debt To Capital Ratio 0.013 ▲0.000 ▼-0.001
Long Term Debt To Capital Ratio 0.000 0.000 0.000
Financial Leverage Ratio 1.245 ▼-0.014 ▼-0.031
Working Capital Turnover Ratio 0.567 ▼-0.062 ▼-0.168
Operating Cash Flow Ratio 0.865 ▲0.085 ▲0.044
Operating Cash Flow Sales Ratio 0.443 ▲0.046 ▲0.043
Free Cash Flow Operating Cash Flow Ratio 0.979 ▼-0.002 ▲0.000
Debt Service Coverage Ratio 0.000 0.000 0.000
Interest Coverage Ratio 0.000 0.000 0.000
Short Term Operating Cash Flow Coverage Ratio 0.000 0.000 0.000
Operating Cash Flow Coverage Ratio 14.764 ▲0.378 ▲0.305
Capital Expenditure Coverage Ratio 48.581 ▼-4.543 ▼-1.026
Dividend Paid And Capex Coverage Ratio 48.581 ▼-4.543 ▼-1.026
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple 25.743 ▼-12.553 ▼-19.706

Key metrics

MetricTrend20262025202420232022
Market cap$33.37B$37.76B$33.30B$26.50B$36.25B
Enterprise value$32.05B$36.72B$32.65B$25.68B$35.17B
EV / Sales10.03x13.37x13.81x11.91x19.00x
EV / Op. cash flow22.65x33.68x35.82x32.90x46.00x
EV / Free cash flow23.12x34.33x36.88x33.48x46.87x
EV / EBITDA25.74x38.30x52.22x46.96x64.02x
Net debt / EBITDA-1.06x-1.09x-1.04x-1.51x-1.97x
Current ratio4.88x4.51x4.24x3.94x3.70x
Income quality1.56x1.53x1.73x1.60x1.79x
Graham number$74$60$46$41$35
Graham net-net$35$27$21$17$13
Tax burden76.1%77.7%89.4%95.8%83.4%
Interest burden100.0%100.0%100.0%100.0%100.0%
Working capital$6.36B$4.91B$3.82B$2.96B$2.27B
Invested capital$6.98B$5.51B$4.43B$3.59B$2.91B
Return on assets10.1%9.7%8.9%10.2%11.2%
Operating ROA11.2%10.4%8.0%10.7%14.7%
Return on tangible assets10.7%10.4%9.7%11.4%13.1%
Return on equity12.6%12.2%11.3%13.1%14.7%
Return on invested capital9.5%9.0%8.1%11.5%14.1%
Return on capital employed12.5%11.6%9.1%12.1%17.0%
Earnings yield2.7%1.9%1.6%1.8%1.2%
Free cash flow yield4.2%2.8%2.7%2.9%2.1%
Capex / Op. cash flow2.1%1.9%2.9%1.7%1.9%
Capex / Depreciation57.7%52.1%70.5%35.9%38.5%
Capex / Sales0.9%0.7%1.1%0.6%0.8%
SG&A / Sales22.8%24.1%26.6%26.3%24.8%
R&D / Sales24.0%25.2%26.6%24.1%20.6%
Stock comp / Sales14.8%0.0%0.0%0.0%0.0%
Intangibles / Total assets5.2%6.6%8.5%10.9%14.2%
Days sales outstanding150d140d137d133d137d
Days payables outstanding18d16d17d25d15d
Operating cycle150d140d137d133d137d
Cash conversion cycle132d125d120d108d122d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-11.6%EV / Sales ▼-25.0%EV / EBITDA ▼-32.8%EV / Op. cash flow ▼-11.037Earnings yield ▲+0.008Graham number ▲+14.415
Profitability
Return on equity ▲+0.004Return on assets ▲+0.004Return on invested capital ▲+0.005Return on capital employed ▲+0.008Operating ROA ▲+0.008Income quality ▲+0.031Tax burden ▼-0.016
Efficiency
Days sales outstanding ▲+9.200Days payables outstanding ▲+1.686Operating cycle ▲+9.200Cash conversion cycle ▲+7.514Capex / Sales ▲+0.002R&D / Sales ▼-0.012
Balance-sheet strength
Current ratio ▲+0.374Net debt / EBITDA ▲+0.023Working capital ▲+1450176000.000Invested capital ▲+1462142000.000Intangibles / Total assets ▼-0.014

Change over 5 years

Valuation
Market cap ▼-7.9%EV / Sales ▼-47.2%EV / EBITDA ▼-59.8%EV / Op. cash flow ▼-23.355Earnings yield ▲+0.015Graham number ▲+39.689
Profitability
Return on equity ▼-0.021Return on assets ▼-0.011Return on invested capital ▼-0.046Return on capital employed ▼-0.045Operating ROA ▼-0.035Income quality ▼-0.232Tax burden ▼-0.073
Efficiency
Days sales outstanding ▲+12.735Days payables outstanding ▲+2.824Operating cycle ▲+12.735Cash conversion cycle ▲+9.911Capex / Sales ▲+0.001R&D / Sales ▲+0.034
Balance-sheet strength
Current ratio ▲+1.190Net debt / EBITDA ▲+0.908Working capital ▲+4094170000.000Invested capital ▲+4064296000.000Intangibles / Total assets ▼-0.090

Employee count

Peer market caps